Health ❯Healthcare ❯Patient Care
Dementia Dialysis Pneumonia Support Systems Heart Failure Kidney Disease Alzheimer's Disease Myalgic Encephalomyelitis (ME) Cognitive Decline Renal Failure Access to Care Access to Treatment Sickle Cell Disorder Sickle Cell Crises Elderly Care Alzheimer's Patients Respiratory Diseases Pope Francis Health Medical Updates Heart Disease Support for Healthcare Workers Pope Francis' Health Living with ALS Cancer Treatment Pulmonary Conditions Gestational Diabetes Health Management Rare Diseases Amyotrophic Lateral Sclerosis Pancreatic Cancer Disability Rights Incurable Diseases Dementia Care Neurodegenerative Diseases Disease Management Bladder Cancer Pelvic Pain Dialysis Patients Management Strategies Coeliac Disease Management Heart Conditions Co-morbidities Impact on Family Autoimmune Diseases Cystic Fibrosis Management Sjögren's Disease Transplant Patients Palliative Needs Heart Transplant Patients Duchenne Muscular Dystrophy Batten Disease Elderly Patients Critical Condition Cardiomyopathy Blood Disorders Long Covid Symptoms Long COVID Symptoms Diabetes Sickle Cell Disease Alzheimer's Treatment Cognitive Impairment
The trial success paves the way for regulatory submissions, positioning the drug as the first targeted therapy to modify Sjögren’s disease course.